Resources
Videos & Podcasts
OODA Loop PTSD Breakthrough: Marine Aviator, Ibogaine Therapy, and The Mission to Live
A retired Marine aviator shares his journey through PTSD, rage, and emotional numbness that resisted years of traditional treatment. Jay Kopelman reflects on a life-changing psychedelic retreat that helped him confront trauma and rediscover connection. Now CEO of Mission Within Foundation, he is advocating for greater access to these therapies for veterans.
From the Battlefield to Healing: Jay Kopelman's Journey with Psychedelics
In this powerful and deeply personal episode, Whiz sits down with retired Marine Corps Lieutenant Colonel Jay Kopelman to explore his harrowing journey from the horrors of combat to the depths of trauma and PTSD. Jay shares his story of survival, including an unsuccessful suicide attempt, and his life-changing experiences with psychedelic medicine—ibogaine and Bufo (toad)—that not only saved his life but healed his soul. These treatments helped him understand his relationship with his son, conquer his struggles with alcohol, and find a renewed purpose.
Marines Save Puppy During Intense Fallujah Firefight
In this video, retired Marine Lieutenant Colonel Jay Kopelman recounts his experience rescuing a puppy during a fierce firefight in Fallujah. Originally from Pittsburgh, PA, Jay shares insights into his upbringing and military service.
Be Loyal To Your Team, Friends, and Your Dogs. With Jay Kopelman
Jocko Willink interviews Jay Kopelman, a former U.S. Navy and Marine Corps officer. Kopelman shares compelling stories from his military career, including the rescue of a dog named Lava during the Iraq War, highlighting the deep emotional bonds formed in combat. He reflects on his transition to civilian life, discussing challenges such as PTSD and the importance of community and alternative therapies in the healing process.
The Ibogaine Initiative: Solutions for Opioid Addiction & Brain Injury
From Shadow to Transcendence: The Healing Power of Ibogaine and 5-MeO
The Future of PTSD Treatment: With or Without MDMA
How Does Psychedelic Treatment work for PTSD?
Dr Martín Polanco and Marine Ryan Roberts: A Discussion on the Clinical Psychedelic Retreat Being Used to Treat Veterans and their Family Members
Articles
Ibogaine, LSD and Psilocybin: Trump’s New Order a Medical ‘Turning Point’
President Donald Trump’s new executive order is being viewed as a potential turning point in the medical use of psychedelics, including ibogaine, LSD, and psilocybin, particularly for treating conditions such as PTSD and traumatic brain injuries in service members and veterans. The directive aims to expand research efforts and improve access pathways, reflecting growing interest in alternative therapies, while experts continue to stress the need for rigorous clinical validation and careful oversight.
Psychedelic Therapy May be Coming to Your Doctor's Office as Questions Swirl
Psychedelic-assisted therapy is gaining attention as a potential treatment for mental health conditions such as depression, PTSD, and anxiety, with ongoing research and regulatory discussions shaping its path toward possible clinical use. While early results show promise, questions remain regarding safety, standardization, long-term effects, and how these treatments would be integrated into traditional medical settings under proper oversight.
Trump Signs Executive Order To Fast-Track Psychedelic Research
President Donald Trump has signed an executive order aimed at expediting research into psychedelic compounds such as ibogaine for potential use in treating PTSD and related conditions, with a focus on veteran care. The directive signals a broader federal effort to streamline regulatory pathways and support clinical studies, while acknowledging that these treatments are still in early stages and require further validation for safety and effectiveness.
Public Capitol Hill Forum Examines Veteran Suicide Crisis and Proposed VA Mental Health Reforms
A bipartisan Capitol Hill forum tomorrow, January 14, 2026, brings lawmakers, veterans, and clinicians together to address the veteran suicide crisis and urge passage of VA mental health reforms expanding access to innovative and psychedelic-assisted therapies; Public RSVP: https://luma.com/w8vv1agu | Media RSVP: Marissa Feinberg, [email protected], 917-494-5041.
I Want to Reset My Brain”: Female Veterans Turn to Psychedelic Therapy
Psychedelic therapy is transforming the lives of female veterans by helping them heal from trauma, anxiety, and depression when conventional treatments have failed—offering a path to reclaim their identity, peace, and purpose.
What to Know About Ibogaine
Ibogaine is a powerful, plant-based psychedelic with promising potential to treat addiction and PTSD by helping individuals access and heal deep-rooted trauma—offering hope where traditional therapies often fall short.
Texas set to invest $50 million into psychedelic research at state university
With a $50M state investment into ibogaine research, The Mission Within and UT stand poised to advance clinical studies focused on veteran mental health and recovery.
Mission to Live Foundation Partners with Psychedelic Medicine Coalition to Support Federal Legislation Expanding Access to Ibogaine Therapy for Veterans
The Mission to Live Foundation has partnered with the Psychedelic Medicine Coalition to support federal legislation expanding access to ibogaine therapy for veterans through specialized VA centers.
Revolutionizing PTSD Treatment: Psychedelic Research for Veteran
Our Executive Director, Jay Kopelman, opens up about his experience with psychedelic therapy and what it was like to go through treatment at The Mission Within.
From personal challenges to profound breakthroughs, he reminds us: “Every journey is different.” Jay’s story is a testament to the courage it takes to heal and the hope these therapies can bring.
Psychoactive Drug Ibogaine Effectively Treats Traumatic Brain Injury in Special Ops Military Vets
A Stanford Medicine study found that ibogaine, a psychoactive compound, significantly improved PTSD, depression, anxiety, and overall functioning in veterans with traumatic brain injuries. Participants reported an average 88% reduction in PTSD symptoms one month post-treatment.
News
Apply
Apply for a Retreat Scholarship
Join Our Mailing List
Subscribe
Contact Us
